These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 8737229)

  • 21. [Usefulness of erythropoietin in the treatment of anemia of prematurity. Influence of birth weight].
    Carbonell Estrany X; Figueras Aloy J; Pérez Fernández JM; Fernández López A; González Luis G; Salvía Roiges MD
    An Esp Pediatr; 1999 Sep; 51(3):281-6. PubMed ID: 10575752
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recombinant human erythropoietin therapy for treatment of anemia of prematurity in very low birth weight infants: a randomized, double-blind, placebo-controlled trial.
    Kumar P; Shankaran S; Krishnan RG
    J Perinatol; 1998; 18(3):173-7. PubMed ID: 9659643
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of 2 iron doses in infants receiving recombinant human erythropoietin therapy.
    Nazir S; Peverini RL; Deming DD; Hopper AO; Vyhmeister NR
    Arch Pediatr Adolesc Med; 2002 Jun; 156(6):540-4. PubMed ID: 12038884
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Decreasing reticulocyte counts associated with declining post-dose erythropoietin plasma levels in anaemia of prematurity.
    Meister B; Khoss A; Burda G; Bock W; Kolmer M; Lischka A; Pollak A
    Biol Neonate; 1998 Dec; 74(6):409-15. PubMed ID: 9784632
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Double blind trial of recombinant human erythropoietin in preterm infants.
    Emmerson AJ; Coles HJ; Stern CM; Pearson TC
    Arch Dis Child; 1993 Mar; 68(3 Spec No):291-6. PubMed ID: 8466265
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of different dosing regimens for recombinant human erythropoietin in a simulated perisurgical setting: the importance of iron availability in optimizing response.
    Rutherford CJ; Schneider TJ; Dempsey H; Kirn DH; Brugnara C; Goldberg MA
    Am J Med; 1994 Feb; 96(2):139-45. PubMed ID: 8109598
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A comparison of oral and intravenous iron supplementation in preterm infants receiving recombinant erythropoietin.
    Meyer MP; Haworth C; Meyer JH; Commerford A
    J Pediatr; 1996 Aug; 129(2):258-63. PubMed ID: 8765624
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of subcutaneous recombinant human erythropoietin (r-HuEPO) on anemia in cancer patients receiving platinum-based chemotherapy.
    Malik IA; Khan ZK; Hakimali A; Sabih M; Rehman G
    J Pak Med Assoc; 1998 May; 48(5):127-31. PubMed ID: 9813972
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of early erythropoietin therapy on the transfusion requirements of preterm infants below 1250 grams birth weight: a multicenter, randomized, controlled trial.
    Ohls RK; Ehrenkranz RA; Wright LL; Lemons JA; Korones SB; Stoll BJ; Stark AR; Shankaran S; Donovan EF; Close NC; Das A
    Pediatrics; 2001 Oct; 108(4):934-42. PubMed ID: 11581447
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recombinant human erythropoietin treatment: investigational new drug protocol for the anemia of the acquired immunodeficiency syndrome. Overall results.
    Phair JP; Abels RI; McNeill MV; Sullivan DJ
    Arch Intern Med; 1993 Dec; 153(23):2669-75. PubMed ID: 8250662
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of intravenous iron supplementation on erythropoiesis in erythropoietin-treated premature infants.
    Pollak A; Hayde M; Hayn M; Herkner K; Lombard KA; Lubec G; Weninger M; Widness JA
    Pediatrics; 2001 Jan; 107(1):78-85. PubMed ID: 11134438
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Potential for treatment of anaemia of prematurity with recombinant human erythropoietin: preliminary results.
    Phibbs RH; Shannon KM; Mentzer WC
    Acta Haematol; 1992; 87 Suppl 1():28-33. PubMed ID: 1574965
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Early erythropoietin use for the prevention of anemia in infant premature].
    Salvadó A; Ramolfo P; Escobar M; Núñez A; Aguayo I; Standen J; Sánchez L; Cabello A
    Rev Med Chil; 2000 Dec; 128(12):1313-7. PubMed ID: 11227239
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Follow-up of very low birth weight infants after erythropoietin treatment to prevent anemia of prematurity.
    Soubasi V; Kremenopoulos G; Diamanti E; Tsantali C; Sarafidis K; Tsakiris D
    J Pediatr; 1995 Aug; 127(2):291-7. PubMed ID: 7636658
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Efficacy of early erythropoietin use in critically ill, very-low-birthweight premature newborn infants: controlled clinical trial].
    Lima-Rogel V; Torres-Montes A; Espinosa Griesse S; Villegas Alvarez C; Hernández-Sierra F; Bissett Mandeville P; Correa González C
    Sangre (Barc); 1998 Jun; 43(3):191-5. PubMed ID: 9741224
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recombinant human erythropoietin in the treatment of anemia associated with human immunodeficiency virus (HIV) infection and zidovudine therapy. Overview of four clinical trials.
    Henry DH; Beall GN; Benson CA; Carey J; Cone LA; Eron LJ; Fiala M; Fischl MA; Gabin SJ; Gottlieb MS
    Ann Intern Med; 1992 Nov; 117(9):739-48. PubMed ID: 1416576
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [HuEPO treatment of anemia in preterm infants].
    Galligani L; Perona A
    Minerva Pediatr; 1994 Nov; 46(11):521-6. PubMed ID: 7870011
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Factors associated with successful epoetin alfa therapy in premature infants.
    Reiter PD; Rosenberg AA; Valuck RJ
    Ann Pharmacother; 2000 Apr; 34(4):433-9. PubMed ID: 10772426
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recombinant erythropoietin compared with erythrocyte transfusion in the treatment of anemia of prematurity.
    Ohls RK; Christensen RD
    J Pediatr; 1991 Nov; 119(5):781-8. PubMed ID: 1941387
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of prolonged low doses of recombinant human erythropoietin during submaximal and maximal exercise.
    Russell G; Gore CJ; Ashenden MJ; Parisotto R; Hahn AG
    Eur J Appl Physiol; 2002 Mar; 86(5):442-9. PubMed ID: 11882931
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.